NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8155.00-68.9 (-0.84 %)
PREV CLOSE ( ) 8223.90
OPEN PRICE ( ) 8248.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 988
TODAY'S LOW / HIGH ( )8115.00 8274.00
52 WK LOW / HIGH ( )5329.7 9370.35
NSE8143.95-76.6 (-0.93 %)
PREV CLOSE( ) 8220.55
OPEN PRICE ( ) 8295.00
BID PRICE (QTY) 8124.00 (1)
OFFER PRICE (QTY) 8144.00 (2)
VOLUME 17079
TODAY'S LOW / HIGH( ) 8101.00 8295.00
52 WK LOW / HIGH ( )5400 9380
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 02-05 1956
Management Info
Aditya Narayan - Chairman Rodolfo Hrosz - Managing Director
Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
27Mar Sanofi India enters into partnership w
Sanofi India (SIL) and Sanofi Healthcare India (together referred as ‘Sa..
27Mar Sanofi India shines on entering into p
Sanofi India is currently trading at Rs. 8049.00, up by 338.15 points or..
12Mar Sanofi India informs about loss of sha
Sanofi India has informed that the Company has received communication fr..
11Mar Sanofi India informs about loss of sha
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosur..
26Feb Sanofi India informs about outcome of
Sanofi India has informed that it enclosed the presentation made to the..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit13776032
Gross Profit 1888 8458
Operating Profit 19948693
Net Sales 693928511
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 829.95 (8.46%)
M.Cap (Rs. in Cr)387.18
Natural Capsules (BSE)
 378.00 (17.35%)
M.Cap (Rs. in Cr)319.36
Mankind Pharma (BSE)
 2386.65 (2.09%)
M.Cap (Rs. in Cr)96007.03
Strides Pharma Scien (BSE)
 893.35 (5.61%)
M.Cap (Rs. in Cr)8123.93
Ajanta Pharma (BSE)
 2133.30 (2.05%)
M.Cap (Rs. in Cr)27069.35
MORE
Shareholding Pattern
PROMOTERS 60.4%
MUTUAL FUNDS/UTI 11.67%
FI/BANKS/INSURANCE 11.17%
NON-INSTITUTION 10.61%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.